<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34783967</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-270X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Biomolecular NMR assignments</Title><ISOAbbreviation>Biomol NMR Assign</ISOAbbreviation></Journal><ArticleTitle><sup>1</sup>H, <sup>13</sup>C and <sup>15</sup>N resonance assignments and solution structures of the two RRM domains of Matrin-3.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>49</EndPage><MedlinePgn>41-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12104-021-10057-0</ELocationID><Abstract><AbstractText>Matrin-3 is a multifunctional protein that binds to both DNA and RNA. Its DNA-binding activity is linked to the formation of the nuclear matrix and transcriptional regulation, while its RNA-binding activity is linked to mRNA metabolism including splicing, transport, stabilization, and degradation. Correspondingly, Matrin-3 has two zinc finger domains for DNA binding and two consecutive RNA recognition motif (RRM) domains for RNA binding. Matrin-3 has been reported to cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) when its disordered region contains pathogenic mutations. Simultaneously, it has been shown that the RNA-binding activity of Matrin-3 mediated by its RRM domains, affects the formation of insoluble cytoplasmic granules, which are related to the pathogenic mechanism of ALS/FTD. Thus, the effect of the RRM domains on the phase separation of condensed protein/RNA mixtures has to be clarified for a comprehensive understanding of ALS/FTD. Here, we report the <sup>1</sup>H, <sup>15</sup>N, and <sup>13</sup>C resonance assignments of the two RNA binding domains and their solution structures. The resonance assignments and the solution structures obtained in this work will contribute to the elucidation of the molecular basis of Matrin-3 in the pathogenic mechanism of ALS and/or FTD.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Fahu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kuwasako</LastName><ForeName>Kanako</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, 202-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takizawa</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, 202-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuda</LastName><ForeName>Kengo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagata</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Advanced Energy and Graduate School of Energy Science, Kyoto University, Gokasho, Uji, Kyoto, 611-0011, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN Yokohama NMR Facility, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Naohiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN Yokohama NMR Facility, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kigawa</LastName><ForeName>Takanori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN Quantitative Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ntert</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Tatsuo Miyazawa Memorial Program, RIKEN Genomic Sciences Center, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomolecular Magnetic Resonance, Institute of Biophysical Chemistry, Goethe-University Frankfurt am Main, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Tokyo Metropolitan University, 1-1 Minami-Ohsawa, Hachioji, Tokyo, 192-0397, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirouzu</LastName><ForeName>Mikako</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Shigeyuki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan. yokoyama@riken.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN Structural Biology Laboratory, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. yokoyama@riken.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN Cluster for Science, Technology and Innovation Hub, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan. yokoyama@riken.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muto</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8073-7077</Identifier><AffiliationInfo><Affiliation>RIKEN Center for Life Science and Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. ymuto@musashino-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>RIKEN, Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama, 230-0045, Japan. ymuto@musashino-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, 202-8585, Japan. ymuto@musashino-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biomol NMR Assign</MedlineTA><NlmUniqueID>101472371</NlmUniqueID><ISSNLinking>1874-270X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071377" MajorTopicYN="N">RNA Recognition Motif</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Matrin-3</Keyword><Keyword MajorTopicYN="N">RNA binding domain</Keyword><Keyword MajorTopicYN="N">RRM</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34783967</ArticleId><ArticleId IdType="doi">10.1007/s12104-021-10057-0</ArticleId><ArticleId IdType="pii">10.1007/s12104-021-10057-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed MM, Barmada SJ (2021) Matrin 3 in neuromuscular disease: physiology and pathophysiology. JCI Insight 6:e143948. https://doi.org/10.1172/jci.insight.143948</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Pantano S, D&#x2019;Ambrogio A, Buratti E, Brindisi A, Marchetti C, Romano M, Baralle FE (2005) Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348:575&#x2013;588. https://doi.org/10.1016/j.jmb.2005.02.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.02.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandziulis RJ, Swanson MS, Dreyfuss G (1989) RNA-binding proteins as developmental regulators. Genes Dev 3:431&#x2013;437. https://doi.org/10.1101/gad.3.4.431</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.3.4.431</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Vest KE, Pavlath GK, Corbett AH (2017) Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Res 45:10706&#x2013;10725. https://doi.org/10.1093/nar/gkx786</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx786</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgrader P, Dey R, Berezney R (1991) Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain. J Biol Chem 266:9893&#x2013;9899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)92902-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatter M, Dunin-Horkawicz S, Grishina I, Maris C, Thore S, Maier Y, Binderreif A, Bujnicki JM, Allain FHT (2015) The signature of the five-Stranded vRRM Fold defined by FUnctional, Structural and Computational Analysis of the hnRNP L protein. J Mol Biol 427:3001&#x2013;3022. https://doi.org/10.1016/j.jmb.2015.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.05.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehringer A, Garcia-Mansfield K, Singh G, Bakkar N, Pirrotte P, Bowser R (2017) ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci Rep 7:14529&#x2013;14542. https://doi.org/10.1038/s41598-017-14924-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14924-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276:36337&#x2013;36343. https://doi.org/10.1074/jbc.M104236200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd CG, Dreyfuss G (1994) Conserved structures and diversities of function of RNA binding proteins. Science 265:615&#x2013;621. https://doi.org/10.1126/science.8036511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8036511</ArticleId></ArticleIdList></Reference><Reference><Citation>Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, Merz KM Jr, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668&#x2013;1688. https://doi.org/10.1002/jcc.20290</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanagh J, Fairbrother WJ, Palmer AG III, Skelton NJ, Rance M (2007) Protein NMR spectroscopy. Principles and practice, 2nd edn. Academic Press, San Diego</Citation></Reference><Reference><Citation>&#x10c;esnik AB, Motaln H, Rogelj B (2020) The impact of ALS-associated genes hnRNPA1, MATR3, VCP and UBQLN2 on the severity of TDP-43 aggregation. Cells 9:1791&#x2013;1801. https://doi.org/10.3390/cells9081791</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9081791</ArticleId></ArticleIdList></Reference><Reference><Citation>Clore GM, Gronenborn AM (1998) New methods of structure refinement for macromolecular structure determination by NMR. Proc Natl Acad Sci USA 95:5891&#x2013;5898. https://doi.org/10.1073/pnas.95.11.5891</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.11.5891</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho MB, Attig J, Bellora N, K&#xf6;nig J, Hallegger M, Kayikci M, Eyras E, Ule J, Smith CWJ (2015) Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J 34:653&#x2013;668. https://doi.org/10.15252/embj.201489852</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201489852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornilescu G, Delaglio F, Bax A (1999) Backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13:289&#x2013;302. https://doi.org/10.1023/a:1008392405740</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1008392405740</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung G-YR, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGG GCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256. https://doi.org/10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based in UNIX pipes. J Biomol NMR 6:277&#x2013;293. https://doi.org/10.1007/bf00197809</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00197809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego-Iradi MC, Strunk H, Crown AM, Davila R, Brown H, Rodriguez-Lebron E, Borchelt DR (2019) N-terminal sequences in matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements. Lab Invest 99:1030&#x2013;1040. https://doi.org/10.1038/s41374-019-0260-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0260-7</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ntert P (2004) Automated NMR structure calculation with CYANA. Methods Mol Biol 278:353&#x2013;378. https://doi.org/10.1385/1-59259-809-9:353</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-809-9:353</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ntert P, Buchner L (2015) Combined automated NOE assignment and structure calculation with CYANA. J Biomol NMR 62:453&#x2013;471. https://doi.org/10.1007/s10858-015-9924-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-015-9924-9</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ntert P, Mumenthaler C, W&#xfc;thrich K (1997) Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 273:283&#x2013;298. https://doi.org/10.1006/jmbi.1997.1284</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1997.1284</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann T, G&#xfc;ntert P, W&#xfc;thrich K (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319:209&#x2013;227. https://doi.org/10.1016/s0022-2836(02)00241-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-2836(02)00241-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Nakamura K, Tsukada S, Sugano N (1993a) Purification and characterization of nuclear scaffold proteins which bind to a highly repetitive bent DNA from rat liver. Biochim Biophys Acta 1174:162&#x2013;170. https://doi.org/10.1016/0167-4781(93)90110-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-4781(93)90110-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Tsukada S, Sugano N (1993b) Properties of a DNA-binding protein from rat nuclear scaffold fraction. Biochem Biophys Res Commun 197:336&#x2013;342. https://doi.org/10.1006/bbrc.1993.2480</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1993.2480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Ohzeki H, Hirose N, Sugano N (1998) Involvement of phosphorylation in binding of nuclear scaffold proteins from rat liver to a highly repetitive DNA component. Biochim Biophys Acta 1396:88&#x2013;96. https://doi.org/10.1016/s0167-4781(97)00176-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-4781(97)00176-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Ohzeki H, Sugano N, Hiraga K (2000) Transcription modulation by a rat nuclear scaffold protein, P130, and a rat highly repetitive DNA component or various types of animal and plant matrix or scaffold attachment regions. Biochem Biophys Res Commun 279:282&#x2013;287. https://doi.org/10.1006/bbrc.2000.3938</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Usui T, Morita Y, Hirose N, Okazaki M, Sugano N, Hiraga K (2006) Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim Biophys Acta 1759:195&#x2013;207. https://doi.org/10.1016/j.bbaexp.2006.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbaexp.2006.04.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Iradi MCG, Triplett JC, Thomas JD, Davila R, Crown AM, Brown H, Lewis J, Swanson MS, Xu G, Rodriguez-Lebron E, Borchelt DR (2018) Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci Rep 8:4049&#x2013;4063. https://doi.org/10.1038/s41598-018-21371-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21371-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, Hatano M, Norihiro Suzuki N (2017) RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration. Sci Transl Med 9:eaah5436. https://doi.org/10.1126/scitranslmed.aah5436</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah5436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chena J, Kuang L, Arenas A, Zhai J, Zhu H, Gala J (2016) Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta 1862:2004&#x2013;2014. https://doi.org/10.1016/j.bbadis.2016.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.07.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kigawa T, Yabuki T, Matsuda N, Matsuda T, Nakajima R, Tanaka A, Yokoyama S (2004) Preparation of Escherichia coli cell extract for highly productive cell-free protein expression. J Struct Funct Genomics 5:63&#x2013;68. https://doi.org/10.1023/B:JSFG.0000029204.57846.7d</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:JSFG.0000029204.57846.7d</ArticleId></ArticleIdList></Reference><Reference><Citation>Koradi R, Billeter M, W&#xfc;thrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graphics 14:51&#x2013;55. https://doi.org/10.1016/0263-7855(96)00009-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0263-7855(96)00009-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kula A, Gharu L, Marcello A (2013) HIV-1 pre-mRNA commitment to Rev mediated export through PSF and Matrin 3. Virology 435:329&#x2013;340. https://doi.org/10.1016/j.virol.2012.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.10.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo P-H, Doudeva LG, Wang Y-T, Shen C-KJ, Yuan HS (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 37:1799&#x2013;1808. https://doi.org/10.1093/nar/gkp013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp013</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR:programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477&#x2013;486. https://doi.org/10.1007/bf00228148</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00228148</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, Gan-Or Z, Spiegelman D, Laurent SB, Szuto A, Hodgkinson A, Dionne-Laporte A, Provencher P, de Carvalho M, Orr&#xf9; S, Brunet D, Bouchard J-P, Awadalla P, Dupr&#xe9; N, Dion PA, Rouleau GA (2016) Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 37:209.e17-209.e21. https://doi.org/10.1016/j.neurobiolaging.2015.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Koshiba S, Hayashi F, Tochio N, Tomizawa T, Kasai T, Yabuki T, Motoda Y, Harada T, Watanabe S, Inoue M, Hayashizaki Y, Tanaka A, Kigawa T, Yokoyama S (2008) Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode. J Biol Chem 283:27165&#x2013;27178. https://doi.org/10.1074/jbc.M803892200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M803892200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K-P, Tsai P-C, Liao Y-C, Chen W-T, Tsai C-P, Soong B-W, Lee Y-C (2015) Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 36:2005.e1-2005.e4. https://doi.org/10.1016/j.neurobiolaging.2015.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guill&#xe9;n-Boixet J, Franzmann TM, Jahnel M, Marrone L, Chang YT, Sterneckert J, Tomancak P, Anthony Hyman A, Simon Alberti S (2018) RNA buffers the phase separation behavior of prion-like RNA-binding proteins. Science 360:918&#x2013;921. https://doi.org/10.1126/science.aar7366</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AM, Barmada SJ (2021) Matrin 3 in neuromuscular disease: physiology and pathophysiology. JCI Insight 11:e143948. https://doi.org/10.1172/jci.insight.143948</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143948</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AM, Miguez RA, Li X, Ho Y-S, Eva L, Feldman EL, Barmada SJ (2018) Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife 7:e35977. https://doi.org/10.7554/eLife.35977</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.35977</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, Lattante S, Doronzio PN, Conte A, Tasca G, Monforte M, Patanella AK, Bisogni G, Meleo E, Salvatore La Spada SL, Zollino M, Sabatelli M (2017) Matrin 3 variants are frequent in Italian ALS patients. Neurobiol Aging 49:218. https://doi.org/10.1016/j.neurobiolaging.2016.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.09.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Maris C, Dominguez C, Allain FH (2005) The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J 272:2118&#x2013;2131. https://doi.org/10.1111/j.1742-4658.2005.04653.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.04653.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda T, Koshiba S, Tochio N, Seki E, Iwasaki N, Yabuki T, Inoue M, Yokoyama S, Kigawa T (2007) Improving cell-free protein synthesis for stable-isotope labeling. J Biomol NMR 37:225&#x2013;229. https://doi.org/10.1007/s10858-006-9127-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-006-9127-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder NJ, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Buillard V, Cerutti L, Copley R, Courcelle E, Das U, Daugherty L, Dibley M, Finn R, Fleischmann W, Gough J, Haft D, Hulo N, Hunter S, Kahn D, Kanapin A, Kejariwal A, Labarga A, Langendijk-Genevaux PS, Lonsdale D, Lopez R, Letunic I, Madera M, Maslen J, McAnulla C, McDowall J, Mistry J, Mitchell A, Nikolskaya AN, Orchard S, Orengo C, Petryszak R, Selengut JD, Sigrist CJ, Thomas PD, Valentin F, Wilson D, Wu CH, Yeats C (2007) New developments in the InterPro database. Nucleic Acids Res 35:D224&#x2013;D228. https://doi.org/10.1093/nar/gkl841</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl841</ArticleId></ArticleIdList></Reference><Reference><Citation>Muto Y, Yokoyama S (2012) Structural insight into RNA recognition motifs: versatile molecular Lego building blocks for biological systems. Wires RNA 3:229&#x2013;246. https://doi.org/10.1002/wrna.1107</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu H, Berezney R (1991) Nuclear matrins: identification of the major nuclear matrix proteins. Proc Natl Acad Sci USA 88:10312&#x2013;10316. https://doi.org/10.1073/pnas.88.22.10312</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.22.10312</ArticleId></ArticleIdList></Reference><Reference><Citation>Niimori-Kita K, Tamamaki N, Koizumi D, Niimori D (2018) Matrin-3 is essential for fibroblast growth factor 2-dependent maintenance of neural stem cells. Sci Rep 8:13412&#x2013;13421. https://doi.org/10.1038/s41598-018-31597-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31597-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, Reymond L, Amir-Ahmady B, Pitsch S, Black DL, Allain FH-T (2005) Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science 309:2054&#x2013;2057. https://doi.org/10.1126/science.1114066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1114066</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G, Dupuis L (2020) Role of RNA binding proteins with prion-like domains in muscle and neuromuscular diseases. Cell Stress 4:76&#x2013;91. https://doi.org/10.15698/cst2020.04.217</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2020.04.217</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers R, Garrett DS, March CJ, Frieden EA, Gronenborn AM, Clore GM (1993) The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry 32:6744&#x2013;6762. https://doi.org/10.1021/bi00077a030</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00077a030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Daley EL, Gleixner AM, Mann JR, Kour S, Mawrie D, Anderson EN, Kofler J, Donnelly CJ, Kiskinis E, Pandey UB (2020a) RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3. Acta Neuropathol Commun 8:177&#x2013;197. https://doi.org/10.1186/s40478-020-01060-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01060-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Kour S, Anderson EN, Rajasundaram D, Pandey UB (2020b) RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM. Acta Neuropathol Commun 8:138&#x2013;159. https://doi.org/10.1186/s40478-020-01021-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01021-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, Gueroussov S, Albu M, Zheng H, Yang A, Na H, Irimia M, Matzat LH, Dale RK, Smith SA, Yarosh CA, Kelly SM, Nabet B, Mecenas D, Li W, Laishram RS, Qiao M, Lipshitz HD, Piano F, Corbett AH, Carstens RP, Frey BJ, Anderson RA, Lynch KW, Penalva LOF, Lei EP, Fraser AG, Blencowe BJ, Morris QD, Hughes TR (2013) A compendium of RNA-binding motifs for decoding gene regulation. Nature 499:172&#x2013;177. https://doi.org/10.1038/nature12311</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12311</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita V-M, Kaivorinne A-L, H&#xf6;ltt&#xe4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#xf2; A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268. https://doi.org/10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M, Elkon R, Borodina T, Davydov A, Yaspo M-L, Halperin HE, Shiloh Y (2011) Matrin 3 binds and stabilizes mRNA. PLoS ONE 6:e23882. https://doi.org/10.1371/journal.pone.0023882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M, Doi H, Koyano S, Kubota S, Fukai R, Hashiguchi S, Hayashi N, Kawamoto Y, Kunii M, Tanaka K, Takahashi K, Ogawa Y, Iwata R, Yamanaka S, Takeuchi H, Tanaka F (2018) Matrin 3 Is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am J Pathol 188:507&#x2013;514. https://doi.org/10.1016/j.ajpath.2017.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2017.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda K, Someya T, Kuwasako K, Takahashi M, He F, Unzai S, Inoue M, Harada T, Watanabe S, Terada T, Kobayashi N, Shirouzu M, Kigawa T, Tanaka A, Sugano S, G&#xfc;ntert P, Yokoyama S, Muto Y (2011) Structural basis for the dual RNA-recognition modes of human Tra2-&#x3b2; RRM. Nucleic Acids Res 39:1538&#x2013;1553. https://doi.org/10.1093/nar/gkq854</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq854</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y, Oshima T, Yamamoto M, Reyes CJ, Costa Cruz PH, Shibuya T, Kawahara Y (2017) Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells 22:785&#x2013;798. https://doi.org/10.1111/gtc.12512</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12512</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand EL, Pratt GA, Shishkin AA, Gelboin-Burkhart C, Fang MY, Sundararaman B, Blue SM, Nguyen TB, Surka C, Elkins K, Stanton R, Frank Rigo F, Guttman M, Yeo GW (2016) Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods 13:508&#x2013;514. https://doi.org/10.1038/nmeth.3810</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3810</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Li J, Tang L, Zhang N, Fan D (2016) MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 38:218. https://doi.org/10.1016/j.neurobiolaging.2015.11.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Ng CS, Xiang P, Liu H, Kevin Zhang K, Mohamud Y, Luo H (2020) Dysregulation of RNA-binding proteins in amyotrophic lateral sclerosis. Front Mol Neurosci 13:1&#x2013;11. https://doi.org/10.3389/fnmol.2020.00078</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>